Search

Displaying results 6061 - 6070 of 10000 in total
  1. Drug

    Indanazoline

    go.drugbank.com/drugs/DB13827
    Experimental

    Categories: Heterocyclic Compounds, 1-Ring
  2. Drug

    Cyfluthrin

    go.drugbank.com/drugs/DB13828
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Potassium permanganate

    go.drugbank.com/drugs/DB13831
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Noxytiolin

    go.drugbank.com/drugs/DB13838
    Approved

    It is used for THERAPEUTIC IRRIGATION of infected body cavities - bladder, peritoneum, etc. and as a spray for burns.

    International brands: Noxyflex S
  5. Drug

    Pipenzolate

    go.drugbank.com/drugs/DB13844
    Investigational

    Categories: Heterocyclic Compounds, 1-RingProducts: PIPTALIN 4 MG/ ML PEDİATRİK ORAL DAMLA, 15 ML
  6. Drug

    Nifuroxazide

    go.drugbank.com/drugs/DB13855
    Investigational

    Mixtures: KRODEX F COMPUESTO® CAPSULAS, DIARSET NX® M CAPSULASCategories: Heterocyclic Compounds, 1-Ring
  7. Drug

    Iopentol

    go.drugbank.com/drugs/DB13861
    Experimental

    Iopentol is used as a contrast medium.

    Categories: X-Ray Contrast Media, Iodinated, Compounds used in a research, industrial, or household setting
  8. Drug

    Magnesium phosphate

    go.drugbank.com/drugs/DB13862
    Investigational

    Synonyms: Magnesium phosphate (3:2), Phosphoric acid, magnesium salt (2:3)Mixtures: BLACKMORES EXECUTIVE B TABLET
  9. Drug

    Fosfructose

    go.drugbank.com/drugs/DB13863
    Investigational

    Synonyms: 1,6-di-O-phosphono-D-fructose, D-fructose 1,6-bisphosphateCategories: Compounds used in a research, industrial, or household setting
  10. Drug

    Tisagenlecleucel

    go.drugbank.com/drugs/DB13881
    ApprovedInvestigational

    Tisagenlecleucel is a CD19-directed genetically modified autologous T cell immunotherapy, or a CAR-T cell therapy for B-cell acute lymphoblastic leukemia. … Tisagenlecleucel is an immunocellular therapy that involves autologous T cells that are collected from each individual patient and genetically engineered to express a specific protein called a chimeric

    Synonyms: Tisagenlecleucel-T, CAR.CD19-Redirected T cellsCategories: Genetically-modified Autologous T Cells